TILMONOR 30

TILMONOR 30

Tilmicosin 30% Injection

Composition

Each ml contains:

• Tilmicosin (as phosphate) ............. 300 mg

• Excipients ........................................ q.s. to 1 ml

Pharmaceutical Form

Sterile injectable solution.

Therapeutic Class

Macrolide antibiotic – Long-acting.

Indications

TILMONOR 30 is indicated for the treatment of respiratory infections caused by Tilmicosin-susceptible microorganisms, including:

• Bovine Respiratory Disease (BRD)

• Pneumonia

• Pasteurellosis

• Mannheimiosis

• Mycoplasma infections

Target Species

• Cattle

• Sheep

• Goats

• Camels

⚠️ Not for use in horses.

Mechanism of Action

Tilmicosin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, providing prolonged antibacterial activity in lung tissue.

Dosage & Administration

Cattle, Sheep, Goats & Camels:

• 10 mg Tilmicosin/kg body weight

• (Equivalent to 1 ml per 30 kg body weight)

Route of Administration:

• Subcutaneous (SC) only

⚠️ DO NOT administer intravenously or intramuscularly.

Usually administered as a single dose.

Contraindications

• Hypersensitivity to macrolide antibiotics

• Contraindicated in horses (fatal toxicity)

• Do not use intravenously

• Do not use in lactating animals producing milk for human consumption

Side Effects

• Transient swelling at injection site

• Rare cardiovascular effects if improperly administered

Withdrawal Period (indicative – subject to local regulations)

• Meat:

  • Cattle: 28–35 days

  • Sheep & Goats: 42 days

• Milk:

  • Not permitted for use in lactating animals

Storage Conditions

• Store below 25°C

• Protect from light

• Do not freeze

Presentation

• 50 ml

• 100 ml

• 250 ml multidose vials